Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 51

References for PMC Articles for PubMed (Select 16301627)

1.

Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions.

Hughes MS, Yu YY, Dudley ME, Zheng Z, Robbins PF, Li Y, Wunderlich J, Hawley RG, Moayeri M, Rosenberg SA, Morgan RA.

Hum Gene Ther. 2005 Apr;16(4):457-72.

3.

Failed adoptive immunotherapy with tumor-specific T cells: reversal with low-dose interleukin 15 but not low-dose interleukin 2.

Roychowdhury S, May KF Jr, Tzou KS, Lin T, Bhatt D, Freud AG, Guimond M, Ferketich AK, Liu Y, Caligiuri MA.

Cancer Res. 2004 Nov 1;64(21):8062-7.

4.

Codon usage bias from tRNA's point of view: redundancy, specialization, and efficient decoding for translation optimization.

Rocha EP.

Genome Res. 2004 Nov;14(11):2279-86. Epub 2004 Oct 12. Erratum in: Genome Res. 2004 Dec;14(12):2510.

5.

Coordinate expression and trans presentation of interleukin (IL)-15Ralpha and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis.

Burkett PR, Koka R, Chien M, Chai S, Boone DL, Ma A.

J Exp Med. 2004 Oct 4;200(7):825-34. Epub 2004 Sep 27.

6.

Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance.

Kobayashi H, Dubois S, Sato N, Sabzevari H, Sakai Y, Waldmann TA, Tagaya Y.

Blood. 2005 Jan 15;105(2):721-7. Epub 2004 Sep 14.

7.

Cutting edge: murine dendritic cells require IL-15R alpha to prime NK cells.

Koka R, Burkett P, Chien M, Chai S, Boone DL, Ma A.

J Immunol. 2004 Sep 15;173(6):3594-8.

8.

Tolerance, not immunity, crucially depends on IL-2.

Malek TR, Bayer AL.

Nat Rev Immunol. 2004 Sep;4(9):665-74. Review.

PMID:
15343366
9.

HIV-specific CD8+ T cells exhibit markedly reduced levels of Bcl-2 and Bcl-xL.

Petrovas C, Mueller YM, Dimitriou ID, Bojczuk PM, Mounzer KC, Witek J, Altman JD, Katsikis PD.

J Immunol. 2004 Apr 1;172(7):4444-53.

10.

IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells.

Klebanoff CA, Finkelstein SE, Surman DR, Lichtman MK, Gattinoni L, Theoret MR, Grewal N, Spiess PJ, Antony PA, Palmer DC, Tagaya Y, Rosenberg SA, Waldmann TA, Restifo NP.

Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1969-74. Epub 2004 Feb 4.

11.
12.

IL-15 in the life and death of lymphocytes: immunotherapeutic implications.

Waldmann TA.

Trends Mol Med. 2003 Dec;9(12):517-21. Review. No abstract available.

PMID:
14659465
13.

Adoptive-cell-transfer therapy for the treatment of patients with cancer.

Dudley ME, Rosenberg SA.

Nat Rev Cancer. 2003 Sep;3(9):666-75. Review.

14.

Effects of codon-optimization on protein expression by the human herpesvirus 6 and 7 U51 open reading frame.

Bradel-Tretheway BG, Zhen Z, Dewhurst S.

J Virol Methods. 2003 Aug;111(2):145-56.

PMID:
12880930
15.

Vienna RNA secondary structure server.

Hofacker IL.

Nucleic Acids Res. 2003 Jul 1;31(13):3429-31.

17.

IL-15 promotes the survival of naive and memory phenotype CD8+ T cells.

Berard M, Brandt K, Bulfone-Paus S, Tough DF.

J Immunol. 2003 May 15;170(10):5018-26. Erratum in: J Immunol. 2003 Aug 15;171(4):following 2169.

18.

IL-15R alpha expression on CD8+ T cells is dispensable for T cell memory.

Burkett PR, Koka R, Chien M, Chai S, Chan F, Ma A, Boone DL.

Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4724-9. Epub 2003 Apr 1.

20.

Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity.

Oh S, Berzofsky JA, Burke DS, Waldmann TA, Perera LP.

Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3392-7. Epub 2003 Mar 7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk